REPL

Replimune Group Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 0/10
  • Value↑ 5/10
Replimune Group sales and earnings growth
REPL Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -12.05%
  • FCF Y/Y↓ -47.55%
Replimune Group gross and profit margin trends
REPL Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -51.82%
Replimune Group net debt vs free cash flow
REPL Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -38.6

Replimune Group stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗